Early Access — free while we kick the tires
EdgarHawk

NORRIS JOHN W III

Director

Director
4 filings analyzed · 1 company · Latest 2025-07-24

Never miss a filing from NORRIS JOHN W III

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
LENNOX INTERNATIONAL INC LII 0 4 Net selling

Activity

July 2025
2025-07-24 LENNOX INTERNATIONAL INC LII 10b5-1 Plan
medium
Sell
22,329 shares
$14,875,594
Significance 4/10

Director Norris sells 22,329 shares for $14.9M across 10 transactions on 2025-07-23 via 10b5-1 plan

NORRIS JOHN W III executed 10 separate sales totaling 22,329 shares for $14,875,593.56 on 2025-07-23 under a pre-arranged 10b5-1 trading plan, reducing his holdings from 200,906 to 178,577 shares (-11.1%). The transactions were executed across a narrow price band ($660.51 to $672.29 blended average $666.20), suggesting algorithmic or systematic execution consistent with a scheduled trading program rather than discretionary market timing. As a Form 4 filing for a director position, this represents a material reduction in LII ownership; however, the pre-arranged nature of the plan means the timing reflects prior planning rather than a current signal of changed views about the company.

2025-07-11 LENNOX INTERNATIONAL INC LII 10b5-1 Plan
low
Sell
3,190 shares
$1,957,772
Significance 4/10

Director John W Norris III sold 3,190 shares of LII for $1,957,772.20 across 3 separate sales on 2025-07-10

John W Norris III, a director at Lennox International, executed 3 separate sales totaling 3,190 shares for $1,957,772.20 at prices ranging from $613.13 to $615.01. The blended average price of $613.72 compares to the current price of $616.85, indicating the insider sold slightly below the present market level. Post-transaction, Norris retains 200,906 shares (200.9K shares), representing a modest 1.6% reduction in holdings, which is consistent with routine portfolio activity rather than a signal of material concern. His cross-ticker track record shows only 2 prior open-market sales across all tickers; with no measurable 90-day outcomes yet available from his recent LII transactions (2025-07-01 and 2025-07-03 sells), there is limited evidence of a consistent pattern of sale timing at this company.

2025-07-07 LENNOX INTERNATIONAL INC LII 10b5-1 Plan
low
Sell
3,190 shares
$1,933,140
Significance 3/10

Director John W Norris III sold 3,190 shares of LII at $606.00 on 2025-07-03, retaining 204,096 shares; stock down 12.7% from 52-week high.

Director Norris sold 3,190 shares at $606.00, a modest 1.5% reduction from his 207,286 pre-transaction holdings. The sale occurred near the stock's 52-week high of $678.43, though the current price of $592.09 is now 12.7% below that peak. His trading history at LII is minimal (only one prior trade, also a sell on 2025-07-01), and his broader cross-ticker track record shows just 1 prior sell, providing insufficient pattern data to assess timing consistency. The company reports solid fundamentals with $1.1B quarterly revenue, 7.2% annual growth, and a P/E of 26.16, suggesting the sale reflects portfolio mechanics rather than fundamental deterioration.

2025-07-02 LENNOX INTERNATIONAL INC LII 10b5-1 Plan
low
Sell
3,190 shares
$1,914,000
Significance 3/10

Director John W Norris III sells 3,190 shares of LII at $600.00; retains 207,286 shares post-transaction

Director Norris sold 3,190 shares for $1,914,000.00, reducing his holdings by 1.5% to 207,286 shares. The sale occurred at $600.00, while the current price stands at $602.10—a negligible difference of $2.10. Norris maintains substantial holdings of 207,286 shares in Lennox International, indicating continued significant equity exposure despite the modest reduction. LII trades at a P/E of 26.61 with quarterly revenue of $1,072,600,000.00 and net income of $120,300,000.00; the 7.2% annual revenue growth and robust market cap of $21,365,414,938.80 reflect a mature, profitable business. The sale appears routine in scale relative to his overall position and the company's fundamentals.

Related insiders